Are you Dr. Stanford?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
244 5th Ave
# 9B
New York, NY 10001Phone+1 212-684-3780
Summary
- Dr. Arielle Stanford, MD is a board certified psychiatrist in New York, New York. She is currently licensed to practice medicine in New York and Massachusetts.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1999 - 2003
Washington University in St. Louis School of MedicineClass of 1999
Certifications & Licensure
NY State Medical License 2000 - 2026
MA State Medical License 2011 - 2016- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) Start of enrollment: 2004 Sep 01
Publications & Presentations
PubMed
- 257 citationsElevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.Lawrence S. Kegeles, Xiangling Mao, Arielle D. Stanford, Ragy R. Girgis, Najate Ojeil
Archives of General Psychiatry. 2012-05-01 - 26 citationsLater paternal age and sex differences in schizophrenia symptomsPaul J. Rosenfield, Karine Kleinhaus, Mark Opler, Mary Perrin, Nicole Learned
Schizophrenia Research. 2010-02-01 - 11 citationsReduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.Christoph U Correll, Evan Stein, Christine Graham, Lauren DiPetrillo, Sarah Akerman
Schizophrenia Bulletin. 2023-03-15
Authored Content
- S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
- S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
Grant Support
- Negative Symptoms Of Schizophrenia: From Phenomenology To Targeted TreatmentNational Institute Of Mental Health2011
- Negative Symptoms Of Schizophrenia: From Phenomenology To Targeted TreatmentNational Institute Of Mental Health2007–2011
